- Case report
- Open Access
Solitary accessory and papillary muscle hypertrophy manifested as dynamic mid-wall obstruction and symptomatic heart failure: diagnostic feasibility by multi-modality imaging
BMC Cardiovascular Disorders volume 14, Article number: 34 (2014)
Solitary papillary muscle (PM) hypertrophy is an unique type of hypertrophic cardiomyopathy (HCM), which is characterized by predominant papillary muscle hypertrophy sparing the rest of other left ventricular segments. It has recently drawn our attention about the mechanism of left ventricular mid-cavity obstruction and the influence of pressure gradient in the left ventricular outflow tract (LVOT), thus carries clinical importance.
We reported a symptomatic, 83-year-old woman who presented with dynamic, high resting left ventricle (LV) mid-wall gradient without obvious septal hypertrophy or systolic anterior motion (SAM). Subsequent real-time (RT) three-dimensional echocardiography (3DE) and cardiac magnetic resonance imaging (MRI) demonstrated large, hypertrophic accessory papillary muscles squeezing mid-cavity of left ventricle producing dynamic pressure gradient during systole in the absence of left ventricular wall anomalies.
We proposed that combined use of echocardiography particularly RT-3DE and cardiac magnetic resonance imaging (MRI) can accurately identify this specific type of hypertrophic cardiomyopathy without remarkable traditional features.
Hypertrophic obstructive cardiomyopathy (HOCM) refers to those subjects with significant dynamic left ventricular outflow tract (LVOT) obstruction due to mechanical causes, with most presents with asymmetrical septal hypertrophy resulting in dynamic systolic anterior motion (SAM) of mitral leaflets .
Solitary papillary muscle (PM) hypertrophy, a peculiar form of HCM manifested as predominant PM hypertrophy sparing the rest of other LV segments, has recently gained much attention owing to its mechanical consequences on left ventricular outflow tract (LVOT) pressure gradient formation [2, 3].
A 83-year-old woman with history of hypertension and hyperlipidemia. The blood pressure and hyperlipidemia were well-controlled with medication. She was admitted to our hospital with chest pain on effort and exertional shortness of breath. Her vital sign was stable with blood pressure 131/70 mmHg and heart rate 67 beats per minute at initial presentation. A mid-systolic ejection murmur was heard along the left sternal border with chest X-ray showed minor pulmonary congestion. Incidental high resting LV mid-wall pressure gradient (86 mmHg, Figure 1A) was shown by 2-dimensional echocardiography without LV septal wall thickness (8.5 mm). The LV end-diastolic volume was 90 ml, and LV end-systolic volume was 27 ml. Apparently hypertrophied anterolateral (A) and posteromedial (P) papillary muscles together with a large, third accessory PM were observed (Figure 1C). Neither aortic stenosis nor SAM was observed. Complete ECG disclosed obvious U wave (V1-V4) with normal QT interval (416ms, Figure 1D). Blood level of B-natriuretic peptide was obviously elevated (227 pg/ml).
Repeated 2D transthoracic echocardiogram during hospitalization revealed no more pressure gradient (plummeted to 5 mmHg) after holding diuretics (Figure 1B). Meanwhile, she was in euvolemic state with blood pressure 128/76 mmHg and heart rate 62 beats per minute. To further clarify the spatial relationships between these hypertrophied PMs and other LV wall segments, real-time 3D echocardiography (RT-3DE) was performed and showed nearly complete LV mid-wall cavity obliteration by the these morphological abnormal PMs during end-systolic phase (Figure 2A-B; Additional files 1, 2 and 3). Subsequent MRI study demonstrated normal LV volume (end-diastolic volume: 71.9 ml), unremarkable LV wall abnormalities, normal global LV mass index (79.9 gm/m2) though significantly hypertrophied PMs (total PM mass: 20.2 gm; 13.4 gm/m2 indexed to body surface area; Figure 2C-D) without visible perfusion defects or delayed hyperenhancement (DHE). High temporal resolution Tissue Doppler Imaging (>250 frames per second) further demonstrated markedly diminished diastolic mitral annulus relaxation velocities (1.8 cm/sec for basoseptal and 4.3 cm/sec for basolateral segments; Figure 2E-F). When PMs mass were taken into account (up to 16.8% LV mass; Figure 3A-B), the total LV mass may reach the echocardiographic criteria for LV hypertrophy  (defined as LV mass index >95 gm/m2 in women and > 115 g/m2 in men). Beta-blockade was then prescribed and the symptoms improved drastically during the subsequent follow up.
So far, left ventricular hypertrophy remained the predominant and major phenotypic component of hypertrophied cardiomyopathy . Few cases of dynamic LVOT or mid-cavity obstruction in relation to various morphological papillary muscle anomalies had been reported before, and these may include bifid  or octopus papillary muscle , accessory , single , or solitary papillary muscle hypertrophy . Papillary muscle hypertrophy, when defined by at least one of the two papillary muscles is more than 1.1 cm in either vertical or horizontal diameter, had been recently shown to be a phenotypic variant of HCM [8, 9]. Not until recently, morphological papillary muscle anomalies without features of phenotypic LV hypertrophy (isolated papillary muscle hypertrophy) had gradually been recognized to be an uncommon HCM variant [8, 10]. The clinical features of LV mid-cavity obstruction caused by papillary muscle hypertrophy may vary greatly from asymptomatic to dyspnea, angina, syncope, and even sudden cardiac death [8–10], with prominent U wave and left ventricular hypertrophy by ECG [11, 12], which is concordant with our current case findings.
While HCM subjects with concomitant morphological papillary muscle anomalies may present with higher degree of resting LVOT gradient , it is not surprising that subjects with increasing number of hypertrophied papillary muscles with unchanged ventricular cavity size may have higher probability of causing LV chamber obliteration during systole. So far, there are reports presented with isolated papillary muscle hypertrophy and normal LV wall thickness. Herein, we report a case of morphological papillary muscle anomalies featured by dynamic LV mid-wall obstruction, with subjective exertional chest pain and dyspnea. We further observed in our case that severely impaired LV diastolic function and clinical heart failure  may occur as a consequence of excessive, redundant papillary muscle mass with normal LV mass .
Current guidelines for LV mass calculation do not take papillary muscle mass into account, while our relevant findings may suggest include papillary muscles in LV mass assessment, especially for these morphologically abnormal papillary muscle subjects.
Solitary papillary muscle hypertrophy as an uncommon variant form of HCM with coexisted additional, accessory papillary muscle may develop abnormally high resting LV mid-wall pressure gradient without SAM or significant regional LV wall hypertrophy. Cardiac MRI and RT-3DE may have their peculiar roles in uncovering these cardiac morphological/structural anomalies aiming for a more comprehensive analysis on their spatial relationships.
In conclusion, we recommended that for subjects with unusually high LV mid-wall or LVOT pressure gradient with unrevealing regional LV segment anomalies, RT-3DE and MRI should be considered as a screening tool to disclose these under-diagnosed, specific HCM subjects in daily routine.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
magnetic resonance imaging
Hypertrophic obstructive cardiomyopathy
Left ventricular outflow tract
Systolic anterior motion
Williams LK, Frenneaux MP, Steeds RP: Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr. 2009, 10: iii9-iii14.
Austin BA, Kwon DH, Smedira NG, Thamilarasan M, Lever HM, Desai MY: Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2009, 22 (105): 105-106.
Pacileo M, Cirillo P, Prastaro M, Chiariello M: Latent left ventricular outflow tract obstruction induced by abnormal hypertrophic papillary muscle caused myocardial ischemia. Int J Cardiol. 2009, 132: 270-272. 10.1016/j.ijcard.2007.08.036.
Barbieri A, Bursi F, Mantovani F, Valenti C, Quaglia M, Berti E, Marino M, Modena MG: Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging. 2012, 13: 109-117. 10.1093/ejechocard/jer176.
Ker J: Bigeminy and the bifid papillary muscle. Cardiovasc Ultrasound. 2010, 8: 13-10.1186/1476-7120-8-13.
Shah AS, Kukar A, Chaudhry FA, Sherrid MV: Unusual anomalous single papillary muscle causing symptomatic mid left ventricular cavity obstruction: octopus papillary muscle. J Am Soc Echocardiogr. 2006, 19: 939-
Harrigan CJ, Appelbaum E, Maron BJ, Buros JL, Gibson CM, Lesser JR, Udelson JE, Manning WJ, Maron MS: Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol. 2008, 101: 668-673. 10.1016/j.amjcard.2007.10.032.
Kobashi A, Suwa M, Ito T, Otake Y, Hirota Y, Kawamura K: Solitary papillary muscle hypertrophy as a possible form of hypertrophic cardiomyopathy. Jpn Circ J. 1998, 62: 811-816. 10.1253/jcj.62.811.
Maron MS: Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012, 14: 13-10.1186/1532-429X-14-13.
Correia AS, Pinho T, Madureira AJ, Araujo V, Maciel MJ: Isolated papillary muscle hypertrophy: a variant of hypertrophic cardiomyopathy? Do not miss a hypertrophic cardiomyopathy. Eur Heart J Cardiovas Imaging. 2013, 14: 296-10.1093/ehjci/jes195.
Ker J: Solitary papillary muscle hypertrophy: a new echo-electrocardiographic syndrome? A case report. Angiology. 2007, 58: 502-503. 10.1177/0003319706291159.
Patil NP, Katti K: Unusual papillary muscle hypertrophy in a septuagenarian. J Oscul Surg. 2011, 142: 704-705.
Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P, Garcia MJ, Lever HM, Desai MY: Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2008, 94: 1295-1301.
Kindermann M: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007, 28: 2686-author reply 2686-2687
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/14/34/prepub
The authors declare that they have no competing interests.
KTS was the primary author of the text. CHY assisted in image acquisition and retouching. CLH conceived of the report, provided the images, and modified the manuscript. JYH provided additional supervision. All authors have read and approved the final manuscript.
About this article
Cite this article
Sung, KT., Yun, CH., Hou, C.JY. et al. Solitary accessory and papillary muscle hypertrophy manifested as dynamic mid-wall obstruction and symptomatic heart failure: diagnostic feasibility by multi-modality imaging. BMC Cardiovasc Disord 14, 34 (2014). https://doi.org/10.1186/1471-2261-14-34
- Solitary papillary muscle hypertrophy
- LVOT obstruction
- Hypertrophic cardiomyopathy